Cargando…
IONIS-PKK(Rx) a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production
Kallikrein is the key contact system mediator responsible for the conversion of high-molecular-weight kininogen into the inflammatory vasodilator peptide bradykinin, a process regulated by C1-esterase inhibitor (C1-INH). In hereditary angioedema (HAE), genetic mutations result in deficient or dysfun...
Autores principales: | Ferrone, Jason D., Bhattacharjee, Gourab, Revenko, Alexey S., Zanardi, Thomas A., Warren, Marshelle S., Derosier, Frederick J., Viney, Nicholas J., Pham, Nguyen C., Kaeser, Gwendolyn E., Baker, Brenda F., Schneider, Eugene, Hughes, Steven G., Monia, Brett P., MacLeod, A. Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461157/ https://www.ncbi.nlm.nih.gov/pubmed/30817230 http://dx.doi.org/10.1089/nat.2018.0754 |
Ejemplares similares
-
Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXI(Rx) in Patients With ESRD
por: Walsh, Michael, et al.
Publicado: (2021) -
Antisense Inhibition of Angiotensinogen With IONIS-AGT-L(Rx): Results of Phase 1 and Phase 2 Studies
por: Morgan, Erin S., et al.
Publicado: (2021) -
PKK Suppresses Tumor Growth and is Decreased in Squamous Cell Carcinoma of the Skin
por: Poligone, Brian, et al.
Publicado: (2014) -
PREKALLIKREIN DEFICIENCY IN MAN
por: Wuepper, Kirk D.
Publicado: (1973) -
The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis
por: Fijen, Lauré M., et al.
Publicado: (2022)